No Data
No Data
Form 144 | Mineralys Therapeutics(MLYS.US) Officer Proposes to Sell 199.07K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 18, $Mineralys Therapeutics(MLYS.US)$ Officer Congleton Jon intends to sell 16,607 shares of its common stock on Jun 18, with a total market value of approximately $199.07K
Form 144 | Mineralys Therapeutics(MLYS.US) Officer Proposes to Sell 217.71K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 17, $Mineralys Therapeutics(MLYS.US)$ Officer Congleton Jon intends to sell 17,766 shares of its common stock on Jun 17, with a total market value of approximately $217.71K
Mineralys Therapeutics Inc (MLYS) CEO Jon Congleton Sells 72,797 Shares
Mineralys Therapeutics(MLYS.US) Officer Sells US$924.2K in Common Stock
$Mineralys Therapeutics(MLYS.US)$ Officer Congleton Jon sold 72,797 shares of common stock on Jun 12, 13, 14, 2024 at an average price of $12.6956 for a total value of $924.2K.Source: Announcement Wha
Form 144 | Mineralys Therapeutics(MLYS.US) Officer Proposes to Sell 203.16K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 14, $Mineralys Therapeutics(MLYS.US)$ Officer Congleton Jon intends to sell 16,229 shares of its common stock on Jun 14, with a total market value of approximately $203.16K
Express News | Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.d. to Its Board of Directors
No Data